Immune Checkpoint Inhibitors in Advanced NSCLC: [(18)F]FDG PET/CT as a Troubleshooter in Treatment Response

Introduction: The aim of this study was to investigate whether [(18)F]FDG PET/CT-derived semi-quantitative parameters can predict immunotherapy treatment response in non-small cell lung cancer (NSCLC) patients. Secondly, immune-related adverse events (irAEs) and lymphoid cell-rich organs activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Cristina, Santo, Giulia, Merenda, Nunzio, Branca, Alessia, Mammucci, Paolo, Pizzutilo, Pamela, Gadaleta, Cosmo Damiano, Rubini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471751/
https://www.ncbi.nlm.nih.gov/pubmed/34574022
http://dx.doi.org/10.3390/diagnostics11091681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471751/
https://www.ncbi.nlm.nih.gov/pubmed/34574022
http://dx.doi.org/10.3390/diagnostics11091681

Ejemplares similares